Suppr超能文献

散发性中枢神经系统血管母细胞瘤患者,无 von Hippel-Lindau 病的临床或遗传证据——病例报告及文献复习。

Disseminated central nervous system hemangioblastoma in a patient with no clinical or genetic evidence of von Hippel-Lindau disease-a case report and literature review.

机构信息

Department of Oncology, Akershus University Hospital, Lørenskog, Norway.

Department of Neuropathology, Oslo University Hospital, Oslo, Norway.

出版信息

Acta Neurochir (Wien). 2019 Feb;161(2):343-349. doi: 10.1007/s00701-019-03800-z. Epub 2019 Jan 17.

Abstract

BACKGROUND

Hemangioblastomas (HB) are benign tumors of the central nervous system (CNS) that can appear sporadic or as part of von Hippel-Lindau (VHL) disease. It is often curable with surgical resection, but upon relapse, the disease exhibits a treatment-refractory course.

CASE REPORT

A patient treated for sporadic cerebellar HB relapsed 12 years post-surgery. She developed disseminated disease throughout the CNS, including leptomeningeal manifestations. Repeat surgery and craniospinal radiation therapy were unsuccessful.

CONCLUSION

This case is in line with previous publications on disseminated non-VHL HB. Available treatment options are inefficient, emphasizing the need for improved understanding of HB biology to identify therapeutic targets.

摘要

背景

血管母细胞瘤(HB)是一种中枢神经系统(CNS)的良性肿瘤,可表现为散发性或作为 von Hippel-Lindau(VHL)病的一部分。通过手术切除通常可以治愈,但复发后,疾病表现出难治性病程。

病例报告

一名接受散发性小脑 HB 治疗的患者在手术后 12 年复发。她的疾病在中枢神经系统中广泛扩散,包括软脑膜表现。重复手术和全脑脊髓放射治疗均不成功。

结论

该病例与先前关于弥散性非 VHL HB 的出版物一致。现有的治疗选择效率低下,这强调了需要更好地了解 HB 生物学以确定治疗靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验